flow trial semaglutide nejm ❇️Patients with obesity, type 2 #diabetes and chronic kidney disease are at high risk for kidney failure, cardiovascular events, and death. This study, the now published, evaluated treatment with (# NEJM: Once-Weekly Semaglutide in Adults

To make it easier to remember your dose, stick to the same time each week

This diet is not a quick or strict plan, instead, it is a balanced and practical approach that combines healthy food choices with regular physical activity for people using GLP 1 medicines to support long-term health and better results 6 , 7

However, those with chronic conditions, such as renal or liver impairment, may need modified dosing

Fortunately, there is now a peptide available that may help you lose weight and better manage your diabetes when combined with proper lifestyle changes

Becker, E

This personalized insight is particularly valuable for patients managing multiple conditions, as it helps ensure your weight-loss therapy aligns with your unique genetic pathway profile